Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

news.google.com

"FDA APPROVAL" - Google News

Get the latest updates from "FDA APPROVAL" - Google News directly as they happen.

Follow now < 10 followers

Latest posts

Last updated about 1 hour ago

Werfen Gains US FDA Clearance and CE Mark for Aptiva APS IgA Reagent - Clinical Lab Products

about 9 hours ago

Werfen Gains US FDA Clearance and CE Mark for Aptiva APS IgA...

Tovecimig Submission for Biliary Cancer Is Proceeding Despite FDA Request for New Trial - Targeted Oncology

about 9 hours ago

Tovecimig Submission for Biliary Cancer Is Proceeding Despite FDA Request for New...

Lantheus wins FDA approval for Bravnetsa GEP-NET drug - Mugglehead Investment Magazine

about 8 hours ago

Lantheus wins FDA approval for Bravnetsa GEP-NET drug  Mugglehead Investment Magazine

Strong Earnings, FDA Approval, and Takeover Interest Drive Lantheus Holdings’ (LNTH) Rally - Yahoo Finance

about 8 hours ago

Strong Earnings, FDA Approval, and Takeover Interest Drive Lantheus Holdings’ (LNTH) Rally...

The Holy Grail In Cancer? FDA Mulls New Blood Tests. - Investor's Business Daily

about 3 hours ago

The Holy Grail In Cancer? FDA Mulls New Blood Tests.  Investor's Business...

Galleri, The Blood Test That Can Detect Cancers, Is Up For FDA Approval Today - Forbes

about 2 hours ago

Galleri, The Blood Test That Can Detect Cancers, Is Up For FDA...

FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma - OncLive

about 2 hours ago

FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma  OncLive

FDA Approves Lyrfigtu for Previously Treated FGFR2-Positive Cholangiocarcinoma - Cure Today

about 2 hours ago

FDA Approves Lyrfigtu for Previously Treated FGFR2-Positive Cholangiocarcinoma  Cure Today

FDA Approves Lirafugratinib for Advanced FGFR2+ Cholangiocarcinoma - Oncology Nursing News

about 2 hours ago

FDA Approves Lirafugratinib for Advanced FGFR2+ Cholangiocarcinoma  Oncology Nursing News

FDA Grants Approval to Lirafugratinib for Advanced Cholangiocarcinoma with FGFR2 Alteration - CancerNetwork

about 2 hours ago

FDA Grants Approval to Lirafugratinib for Advanced Cholangiocarcinoma with FGFR2 Alteration  CancerNetwork

FDA Approves Lirafugratinib for Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma - The ASCO Post

about 2 hours ago

FDA Approves Lirafugratinib for Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma...